Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS3AP41 is a **processed pseudogene** of the ribosomal protein S3A gene in humans[5][6][7]. Pseudogenes are non-functional segments of DNA that resemble functional genes but do not produce active proteins. RPS3AP41 does not encode a functional ribosomal protein and is considered a genetic remnant resulting from the duplication and subsequent loss of protein-coding ability of the ancestral RPS3A gene. Pseudogenes generally do not have direct biological functions, are not therapeutic targets, and do not interact with drugs or act as biomarkers. There are many ribosomal protein S3A pseudogenes in the human genome; RPS3AP41 is simply one among them[4][5][7]. It has no established role in disease, pathway, or molecular mechanism.\n\n**Key insights:**\n- **RPS3AP41 is not a therapeutic target** (such as a receptor, enzyme, transporter, etc.), nor does it have a role in cellular signaling, disease mechanisms, or drug interactions[5].\n- The entry is **likely only relevant as a genomic annotation** and not for pharmacological or biomedical targeting.\n- The designation as a “pseudogene” means **it does not code for a functional protein and lacks canonical molecular or biological roles**[4][5][6].\n- The entry is **correct** in so far as it reflects the correct pseudogene, but **incorrect or inappropriate for targeting or therapeutic use**.\n\nIf you need structured details about the functional ribosomal protein S3A (RPS3A), refer to entries for the parent gene rather than processed pseudogenes[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3a pseudogene 41 (RPS3AP41).